Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3

D. Detzen, S. Hoffmann, H. Zulch

Research output: Contribution to JournalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3'. Together they form a unique fingerprint.

Business & Economics

Social Sciences